Results 201 to 210 of about 239,474 (338)

PUMA-p53 Dysregulation and Ki-67 Overexpression Define Unfavorable Prognostic Signatures in Colorectal Cancer. [PDF]

Cancers (Basel)
Mekras A, Tsavdaris D, Mekras D, Vasilakou A, Paramythiotis D, Michalopoulos A, Bobos M.   +6 more
europepmc   +1 more source

Evaluation of gastroenteropancreatic neuroendocrine tumors for Ki 67, p16 and cyclin D1 expression

, 2011
Gülzade Özyalvaçlı, Esra Paşaoğlu, Zuhal Güçin, Kemal Behzatoğlu, Feray Günver, Erol Rüştü Bozkurt   +5 more
openalex   +1 more source

Evaluation of Nuclear Morphometry and Ki-67 Proliferative Marker in Astrocytomas: A Ambispective Study

, 2023
Palak Nanda
openalex   +1 more source

Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis

Advanced Science, EarlyView.
Elemene increases SPP expression by competitively binding with miR‐130a‐5p to suppress SPP mRNA degradation. This led to more antigen/MHC‐I complexes being expressed on the cell surface, which consequently facilitated the recognition and killing of HCC cells by CTLs and enhancing the antitumor immune efficacy of anti‐PD‐1.
Menglan Wang, Mengqing Sun, Heng Dong, Xiaoting Zhang, Jingbo Zhang, Zhengguo Zhang, Mengjie Ni, Lina Li, Yunxin Pei, Xiaoyu Chen, Qian Li, Fangtian Bu, Jiacheng Huang, Liangyu Jiang, Zhuting Fang, Xuliang Chen, Jianxiang Chen, Yiting Qiao, Tian Xie   +18 more
wiley   +1 more source

Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer. [PDF]

J Clin Med
Harsanyi S, Novakova ZV, Neuschlova L, Galbavy S, Danisovic L, Ziaran S, Bevizova K.   +6 more
europepmc   +1 more source

Electrochemiluminescence Drives Photodynamic Therapy In Vivo

Advanced Science, EarlyView.
Electrochemiluminescence (ECL)‐driven photodynamic therapy (PDT) for in vivo cancer treatment is reported for the first time. The flexible ECL patch exhibits stable and intense luminance under alternating current voltage, enabling efficient photosensitization to generate reactive oxygen species that damage cancer cells, thus leading to significant ...
Jia‐Bao Lin, Ling‐Ling Xu, Yong Liu, Hang Gao, Hong‐Yuan Chen, Jing‐Juan Xu   +5 more
wiley   +1 more source

Ki-67 and Tumor Size in Small Bowel Tumors: Findings from an Exploratory Immunohistochemical Analysis. [PDF]

Life (Basel)
Barbu LA, Cercelaru L, Șurlin V, Mogoantă SS, Țenea Cojan TS, Marinescu D, Mărgăritescu ND, Vasile L.   +7 more
europepmc   +1 more source

Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R‐Loop Accumulation and DNA Repair Deficiencies

Advanced Science, EarlyView.
ARID1A, a SWI/SNF complex component, is frequently mutated in colorectal cancer (CRC). CRC with ARID1A/TP53 concurrent mutations shows marked sensitivity to WEE1 inhibition. ARID1A loss induces R‐loop‐mediated replication stress, impairs ATF3 transcription, and amplifies WEE1i‐induced DNA damage, suggesting a promising therapeutic vulnerability ...
Chi Zhang, Yanjing Zhu, Luoyan Ai, Jingyuan Wang, Shan Yu, Yichen Wang, Xiaojing Xu, Mengling Liu, Yiyi Yu, Mengxuan Zhu, Yutong Liu, Zhenghang Xu, Haojie Zhou, Huishan Li, Qihong Huang, Qing Liu, Ke Peng, Tianshu Liu   +17 more
wiley   +1 more source

Are <i>PTTG1</i> variants associated with tumor characteristics and p53/Ki-67 expression in pituitary neuroendocrine tumors. [PDF]

Front Endocrinol (Lausanne)
Baikstiene I, Duseikaite M, Vilkeviciute A, Juskiene M, Makstiene J, Poskiene L, Tamasauskas A, Verkauskiene R, Liutkeviciene R, Zilaitiene B.   +9 more
europepmc   +1 more source

Ki-67 som prognostisk markør for prostatakreft. Betydningen av proliferasjonsraten til prostatakreftceller målt ved bruk av Ki-67

, 2016
Ingeborg Marie Movik
openalex   +1 more source